Merck CDR (CAD Hedged) (MRK : TSX)
Common Stock
$32.25
CAD
+0.24 (0.75%)
Last updated: 2026-09-16
Dividend Declared
3 days ago$0.1887 CAD per share dividend. Ex-dividend date: September 15, 2026 • Payment date: October 15, 2026Upcoming
Get MRK alerts:
MRK
Merck CDR (CAD Hedged)
WealthAwesomePerformance
1 Day
+0.75%
1 Week
-2.06%
1 Month
+6.33%
YTD
+34.26%
Key Statistics
Market Cap
$296.29B
52W High
$34.69
52W Low
$17.16
P/E Ratio
115.18
50 Day MA
$30.49
200 Day MA
$27.47
Beta
-
Dividend Yield
10.37%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/16/2026 | $32.04 | $32.25 | $32.00 | $32.25 | $32.25 | 10,700 |
| 9/15/2026 | $31.95 | $32.06 | $31.70 | $32.01 | $32.01 | 12,600 |
| 9/14/2026 | $32.68 | $32.71 | $32.11 | $32.15 | $32.15 | 4,855 |
| 9/11/2026 | $32.32 | $32.39 | $31.95 | $32.06 | $32.06 | 25,839 |
| 9/10/2026 | $32.86 | $32.86 | $32.16 | $32.17 | $32.17 | 7,701 |
| 9/9/2026 | $33.16 | $33.24 | $32.93 | $32.93 | $32.93 | 2,512 |
| 9/8/2026 | $33.19 | $33.19 | $32.70 | $33.10 | $33.10 | 5,927 |
| 9/4/2026 | $33.48 | $33.48 | $33.42 | $33.45 | $33.45 | 1,300 |
| 9/3/2026 | $33.90 | $33.94 | $33.39 | $33.94 | $33.94 | 6,236 |
| 9/2/2026 | $33.51 | $33.82 | $33.51 | $33.77 | $33.77 | 3,617 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRK's historical volatility
30-Day Vol
41.0%
Annualized
90-Day Vol
34.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$38.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$34.23 | C$29.71 – C$39.43 |
| 60 trading days | C$36.33 | C$29.74 – C$44.37 |
| 90 trading days | C$38.56 | C$30.18 – C$49.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Merck CDR (CAD Hedged)
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 3690.70%
- EPS (Diluted)
- 0.00
- Book Value
- -
Recent Dividends
$0.1887CAD
Ex: Sep 15, 2026
Pay: Oct 15
$0.1915CAD
Ex: Dec 15, 2025
$0.1848CAD
Ex: Sep 15, 2025
$0.1851CAD
Ex: Jun 16, 2025
$0.1837CAD
Ex: Mar 17, 2025
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MRK
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GLO | Global Atomic Corp | $0.71 | +44.90% |
| DIAM | Star Diamond Corp | $0.03 | +25.00% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +14.29% |
| YRB | Yorbeau Resources Inc | $0.06 | +10.00% |
| COPR | Coppernico Metals Inc. | $0.44 | +8.64% |
| NFGC | New Found Gold Corp. | $2.42 | +7.56% |
| TELY | TelyRx Holdings Inc. | $2.25 | +7.14% |
| LABS | Medipharm Labs Corp | $0.07 | +7.14% |
MRK.TO news timeline
1 article covering MRK.TO, most recent first
Latest